The Oral Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) Activity in Double Hit Diffuse Large B Cell Lymphomas (DLBCL) in Preclinical Models & Clinical Activity in Patients with DLBCL
The Oral Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) Activity in Double Hit Diffuse Large B Cell Lymphomas (DLBCL) in Preclinical Models & Clinical Activity in Patients with DLBCL